Clinical Trial Update: Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating combination chemotherapy with or without the investigational agent SU5416 for metastatic colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SU5416 (semaxanib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN